EVOLYBRI
LIVE

Serial Number

79265323

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

EVOLYBRI Trademark

Serial Number: 79265323 • Registration: 5952506

EVOLYBRI is a trademark filed by NOVARTIS AG on June 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 25, 2019

Registration Date

January 7, 2020

Published for Opposition

October 22, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; [ cardiovascular pharmaceuticals; ] dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use [ in hematology and ] in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; [ pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; [ pharmaceutical preparations for the prevention and treatment of hypertension; ] pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma * excluding pharmaceutical preparations in the field of cardiovascular, cardiac, vascular and hematological diseases and disorders *

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 7, 2025 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 7, 2021 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 5, 2021 INPR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 28, 2020 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 28, 2020 COC.
ASSIGNED TO PARALEGAL
Apr 23, 2020 PLGL
LIMITATION FROM THE IB EXAMINED AND ENTERED
Mar 30, 2020 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Mar 27, 2020 LIMG
TEAS SECTION 7 REQUEST RECEIVED
Mar 25, 2020 ES7R
NOTIFICATION PROCESSED BY IB
Mar 20, 2020 GPNX
LIMITATION OF GOODS RECEIVED FROM IB
Mar 13, 2020 LIMG
FINAL DISPOSITION NOTICE SENT TO IB
Feb 29, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 28, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 6, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 19, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 2, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2019 NONP
ASSIGNED TO LIE
Sep 18, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2019 CNSA
ASSIGNED TO EXAMINER
Sep 13, 2019 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 11, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 11, 2019 REAP
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 20, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2019 REPR